Shares of ValiRx plc (LON:VAL – Get Free Report) were down 6.8% during trading on Tuesday . The company traded as low as GBX 0.68 ($0.01) and last traded at GBX 0.70 ($0.01). Approximately 5,912,103 shares traded hands during mid-day trading, a decline of 65% from the average daily volume of 16,815,768 shares. The stock had previously closed at GBX 0.75 ($0.01).
ValiRx Price Performance
The stock has a market cap of £925,126.50, a P/E ratio of -34.95 and a beta of 0.59. The company has a debt-to-equity ratio of 0.49, a current ratio of 6.65 and a quick ratio of 1.27. The business’s fifty day moving average price is GBX 0.91 and its 200 day moving average price is GBX 1.57.
ValiRx Company Profile
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
Featured Articles
- Five stocks we like better than ValiRx
- Differences Between Momentum Investing and Long Term Investing
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- P/E Ratio Calculation: How to Assess Stocks
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
